317 related articles for article (PubMed ID: 30476863)
1. An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based
Xiong Z; Lang L; Gao X; Xiao W; Wang Z; Zhao L
J Pharm Biomed Anal; 2019 Feb; 164():750-758. PubMed ID: 30476863
[TBL] [Abstract][Full Text] [Related]
2. Intergrated metabonomic study of the effects of Guizhi Fuling capsule intervention on primary dysmenorrheal using RP-UPLC-MS complementary with HILIC-UPLC-MS technique.
Lang L; Meng Z; Sun L; Xiao W; Zhao L; Xiong Z
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28906007
[TBL] [Abstract][Full Text] [Related]
3. Systematic screening and characterization of multiple constituents in Guizhi Fuling capsule and metabolic profiling of bioactive components in rats using ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Zhang Y; Cheng Y; Liu Z; Ding L; Qiu T; Chai L; Qiu F; Wang Z; Xiao W; Zhao L; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():474-486. PubMed ID: 28838645
[TBL] [Abstract][Full Text] [Related]
4. Effects and mechanisms of Shaofu-Zhuyu decoction and its major bioactive component for Cold - Stagnation and Blood - Stasis primary dysmenorrhea rats.
Huang X; Su S; Duan JA; Sha X; Zhu KY; Guo J; Yu L; Liu P; Shang E; Qian D
J Ethnopharmacol; 2016 Jun; 186():234-243. PubMed ID: 27060631
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic study of biochemical changes in the plasma and urine of primary dysmenorrhea patients using UPLC-MS coupled with a pattern recognition approach.
Su S; Duan J; Wang P; Liu P; Guo J; Shang E; Qian D; Tang Y; Tang Z
J Proteome Res; 2013 Feb; 12(2):852-65. PubMed ID: 23290075
[TBL] [Abstract][Full Text] [Related]
7. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats.
Cheng Y; Chu Y; Su X; Zhang K; Zhang Y; Wang Z; Xiao W; Zhao L; Chen X
Phytomedicine; 2018 Sep; 48():141-151. PubMed ID: 30195872
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS.
Cheng M; Wu H; Wu H; Liu X; Zhou A
J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine.
Liu P; Duan J; Wang P; Qian D; Guo J; Shang E; Su S; Tang Y; Tang Z
Mol Biosyst; 2013 Jan; 9(1):77-87. PubMed ID: 23111557
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolomics research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats based on
Liu Y; Jin Z; Qin X; Zheng Q
J Pharm Pharmacol; 2020 May; 72(5):748-760. PubMed ID: 32128823
[TBL] [Abstract][Full Text] [Related]
12. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea.
Zhang Y; Su N; Liu W; Wang Q; Sun J; Peng Y
Front Pharmacol; 2021; 12():764904. PubMed ID: 34776980
[TBL] [Abstract][Full Text] [Related]
14. An UPLC-MS/MS method for simultaneous determination of multiple constituents in Guizhi Fuling capsule with ultrafast positive/negative ionization switching.
Zhang RH; Li CR; Yang H; Li MN; Tsim KWK; Li P; Gao W
Chin J Nat Med; 2018 Apr; 16(4):313-320. PubMed ID: 29703331
[TBL] [Abstract][Full Text] [Related]
15. An integrated study of metabolomics and transcriptomics to reveal the anti-primary dysmenorrhea mechanism of Akebiae Fructus.
Ma B; Yang S; Tan T; Li J; Zhang X; Ouyang H; He M; Feng Y
J Ethnopharmacol; 2021 Apr; 270():113763. PubMed ID: 33383110
[TBL] [Abstract][Full Text] [Related]
16. [Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical study].
Liu YJ; Xiao W; Wang ZZ; Zhao BJ; Zhou ZM; Jiang HZ; Jin Z; Wei SB; Wang Z; Wang DM; Xia QH; Lin J; Wang Q
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(12):2019-22. PubMed ID: 24066604
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of rat urine after oral administration of the prescription antipyretic Hao Jia Xu Re Qing Granules by UPLC/Q-TOF-MS.
Yu CQ; Chen JP; Zhong YM; Zhong XL; Tang CP; Yang Y; Lin HQ
Biomed Chromatogr; 2018 Nov; 32(11):e4332. PubMed ID: 29981286
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolic profiling of normal and dysmenorrhea syndrome rats and the effects of Xiang-Fu-Si-Wu Decoction intervention.
Liu P; Duan JA; Guo JM; Qian DW; Shang EX; Tang YP; Su SL
Pharm Biol; 2014 May; 52(5):603-13. PubMed ID: 24262062
[TBL] [Abstract][Full Text] [Related]
19.
Liu S; Yuan X; Ma C; Zhao J; Xiong Z
Anal Biochem; 2020 Dec; 610():113992. PubMed ID: 33075315
[TBL] [Abstract][Full Text] [Related]
20. An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats.
Huang Y; Bo Y; Wu X; Wang Q; Qin F; Zhao L; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():119-30. PubMed ID: 27281385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
